TGF-β1 calcium signaling in osteoblasts
TGF-β1 calcium signaling in osteoblasts
复制标题
DOI:
10.1002/jcb.21180
复制
发表时间:
2007-05-15
影响因子:
4
通讯作者:
Tuan, Rocky S.
中科院分区:
文献类型:
--
作者:
Nesti, Leon J.;Caterson, E. J.;Tuan, Rocky S.
Transforming growth factor-beta 1 (TGF-beta 1) action is known to be initiated by its binding to multiple cell surface receptors containing serine/threonine kinase domains that act to stimulate a cascade of signaling events in a variety of cell types. We have previously shown that TGF-beta 1 and BMP-2 treatment of primary human osteoblasts (HOBs) enhances cell-substrate adhesion. In this report, we demonstrate that TGF-beta 1 elicits a rapid, transient, and oscillatory rise in the intracellular Ca2+ concentration, [Ca2+](i), that is necessary for enhancement of cell adhesion in HOBs but does not alter the phosphorylation state of Smad proteins. This rise in [Ca2+](i) in HOB is not observed in the absence of extracellular calcium or when the cells are treated with the L-type Ca2+ channel blocker, nifeclipine, but is stimulated upon treatment with the L-type Ca2+ channel agonist, Bay K 8644, or under high K+ conditions. The rise in [Ca2+](i) is severely attenuated after treatment of the cells with thapsigargin, a selective encloplasmic reticulum Ca2+ PUMP inhibitor. TGF-beta 1 enhancement of HOB adhesion to tissue culture polystyrene is also inhibited in cells treated with nifeclipine. These data suggest that intracellular Ca2+ signaling is an important second messenger of the TGF-beta 1 signal transcluction pathway in osteoblast function.